by DubaiVAE” January 26, 2025 / CNW/ – on the eve of the Arab health exhibitionYuwell Medical kept his 2025 Global Core Partner Conference in Dubaiand announced one Strategic investments and partnership with in eyesA leading American company in the health of the airways, which emphasizes our joint dedication to promote solutions to medical devices and deeper cooperation.
Alex Wu, chairman of Yuwell Medical, spoke on the Yuwell Medical 2025 Global Core Partner Conference, said that as a leading company in China Home Medical Device industry, Yuwell will rely on internal growth and external mergers and takeovers to promote internationalization. The company has updated its new vision for the next five years: the top three companies will be in the worldwide medical health market of the home base in the middle to the long term. Among them, solutions for respiratory treatment, diabetes care and solutions for emergency services are the three most important strategic sectors. The company will further strengthen its globalization strategy of three aspects: expansion of the organizational structure, recruitment of excellent overseas talents product R&D innovation and innovation of supply chain integration.
He further emphasized: “In the process of realizing the new vision, Yuwell will work hand in hand with global partners to offer users more competitive products and better health solutions.”
During the conference, Yuwell Medical and the American company have formalized their collaboration by a Strategic investments and cooperation memorandumThe further deepening of their partnership in the respiratory segment.
As one of the world’s largest manufacturers of oxygen concentrators, Yuwell Medical is generally recognized for its strong R&D options and advanced production options.
Inogene, a leading American manufacturer of oxygen concentrators, offers extensive experience in portable oxygen concentrator technology. Yuwell, through his entire subsidiary Yuwell (Hong Kong) Holdings Limited, agreed to invest approximately $ 27.2 million In Opsogen, 9.9% of the outstanding shares of the ordinary shares of in eyes represents when taking out this investment.
The two companies try to upgrade device technology through deep cooperation. By combining their expertise and brand in their respective industrial segments and regions, Yuwell and Inogene agree to perform in -depth strategic cooperation on the basis of business synergy in four aspects: international distribution companies, trademark permits and distribution activities, joint research and development, and supply Chain optimization.
